Alzamend Neuro

+$0.01 (+0.44%) As of 3:46 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alzamend Neuro and other ETFs, options, and stocks.

About ALZN

Alzamend Neuro, Inc. is a preclinical stage biopharmaceutical company, which engages in the manufacture of pharmaceutical products. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders.

CEO
Stephan Jackman
Employees
2
Headquarters
Tampa, Florida
Founded
2016

ALZN Key Statistics

Market Cap
197.24M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.21M
High Today
$2.37
Low Today
$2.22
Open Price
$2.31
Volume
500.71K
52 Week High
$33.55
52 Week Low
$2.22

ALZN Earnings

-$0.03
-$0.02
-$0.01
$0.00
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Nov 23, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure